Term Clause Example with 19 Variations from Business Contracts
This page contains Term clauses in business contracts and legal agreements. An example clause is provided at the top of the page, followed by clauses with minor variations. You can view the text differences by selecting the "Show Differences" option.
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Inc. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "P...rogram"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 for such service.View More
Variations of a "Term" Clause from Business Contracts
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 EX-10.13 17 tm2115679d11_ex10-13.htm EXHIBIT 10.13 Exhibit 10.4 SERES THERAPEUTICS, INC. 10.13 IMMUNEERING CORPORATION NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Inc. Immuneering Corporation (the "Company") shall rece...ive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). Date"), subject to the closing of such offering. I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman Chair of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $30,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 EX-10.1 2 fixx-ex10_1.htm EX-10.1 EX-10.1 Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM 10.1 Homology Medicines, Inc. Non-Employee Director Compensation Program Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Homology Medicines, I...nc. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). "Program"), as amended and restated by the Board effective September 6, 2022 (the "Effective Date"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION Cash Compensation A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. Board (the Annual Retainer"). B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: retainers (each, a "Committee Member Retainer"): 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or shall receive an additional annual retainer of $35,000 for such service. A Non-Employee Director serving as Lead Independent Director shall receive an additional annual retainer of $20,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 9 tm219739d12_ex10-4.htm EXHIBIT 10.4 Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Rapid Micro Biosystems, Inc. Non-Employee Director Compensation Program Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Rapid Micro Biosystems, In...c. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION Cash Compensation A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman Chair of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman Chair of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $40,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 3 EX-10.5 6 d600976dex105.htm EX-10.5 EX-10.5 Exhibit 10.4 SERES THERAPEUTICS, 10.5 ALZHEON, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Alzheon, Inc. (the "Company") shall receive cash and equity compensation as ...set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $40,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 |US-DOCS\132589328.2|| EX-10.1 2 mcrb-ex10_1.htm EX-10.1 EX-10.1 Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM 10.1 Seres Therapeutics, Inc. Non-Employee Director Compensation Program (as amended effective June 22, 2022) (the "Effective Date") Non-employee members o...f the board of directors (the "Board") of Seres Therapeutics, Inc. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION Cash Compensation A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $45,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $35,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 3 EX-10.5 6 d503060dex105.htm EX-10.5 EX-10.5 Exhibit 10.4 SERES THERAPEUTICS, 10.5 ALZHEON, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Alzheon, Inc. (the "Company") shall receive cash and equity compensation as ...set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $40,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $40,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 |BN\1062045.3|| EX-10.3 3 mcrb-20210630ex10_3.htm EX-10.3 EX-10.3 Exhibit 10.4 SERES THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM 10.3 Seres Therapeutics, Inc. Non-Employee Director Compensation Program (as amended effective June 2, 2021) Non-employee members of the board of director...s (the "Board") of Seres Therapeutics, Inc. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION Cash Compensation A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 $45,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $35,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. * * * * * EX-10.4 12 d816354dex104.htm EX-10.4 EX-10.4 EX-10.3 9 d72917dex103.htm EX-10.3 EX-10.3 Exhibit 10.4 SERES 10.3 FREQUENCY THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Frequency Therapeutics, Inc. (the "Company") shall receive cash and equity compensation as s...et forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION Cash Compensation A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $30,000 for such service. View More
Term. The maximum term of each stock option granted to a Non-Employee Director hereunder shall be ten (10) years from the date the option is granted. III. COMPENSATION LIMITS Notwithstanding anything to the contrary in this Program, all compensation payable under this Program will be subject to any limits on the maximum amount of Non-Employee Director compensation set forth in the Equity Plan, as in effect from time to time. * * * * * EX-10.4 12 d816354dex104.htm 8 a2228810zex-10_4.htm EX-10.4 EX-10.4... Exhibit EXHIBIT 10.4 SERES THERAPEUTICS, SELECTA BIOSCIENCES, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Non-employee members of the board of directors (the "Board") of Seres Therapeutics, Selecta Biosciences, Inc. (the "Company") shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this "Program"). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a "Non-Employee Director") who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and/or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to stock options granted pursuant to the Program. This Program shall become effective on the date of the effectiveness of the Company's Registration Statement on Form S-1 relating to the initial public offering of common stock (the "Effective Date"). I. CASH COMPENSATION A. Annual Retainers. Each Non-Employee Director shall receive an annual retainer of $35,000 for service on the Board. B. Additional Annual Retainers. In addition, each Non-Employee Director shall receive the following annual retainers: 1. Chairman of the Board or Lead Independent Director. A Non-Employee Director serving as Chairman of the Board or Lead Independent Director shall receive an additional annual retainer of $20,000 $15,000 for such service. View More
